• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义发作性偏头痛和慢性偏头痛之间的差异。

Defining the differences between episodic migraine and chronic migraine.

机构信息

Department of Neurology, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany.

出版信息

Curr Pain Headache Rep. 2012 Feb;16(1):86-92. doi: 10.1007/s11916-011-0233-z.

DOI:10.1007/s11916-011-0233-z
PMID:22083262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3258393/
Abstract

Chronic migraine (CM) and episodic migraine (EM) are part of the spectrum of migraine disorders, but they are distinct clinical entities. Population-based studies have shown that those with CM demonstrate higher individual and societal burden because they are significantly more disabled than those with EM and have greater impaired quality of life both inside and outside the home. Proper diagnosis of both conditions requires clearly defined clinical criteria. Diagnosis enables the initiation of appropriate treatments and risk-factor modification, which ultimately improve functional status and quality of life for persons with migraine. Recognizing that both disorders are on the spectrum of migraine, this review serves as a guide to define the disease state of CM as distinct from EM in terms of clinical, epidemiological, sociodemographic, and comorbidity profiles.

摘要

慢性偏头痛(CM)和发作性偏头痛(EM)是偏头痛疾病谱的一部分,但它们是不同的临床实体。基于人群的研究表明,CM 患者的个体和社会负担更高,因为他们比 EM 患者的残疾程度更严重,并且在家庭内外都有更差的生活质量。这两种疾病的正确诊断都需要明确的临床标准。诊断可以启动适当的治疗和危险因素的改变,从而最终改善偏头痛患者的功能状态和生活质量。鉴于这两种疾病都在偏头痛谱中,本综述旨在从临床、流行病学、社会人口统计学和共病特征方面将 CM 定义为与 EM 不同的疾病状态。

相似文献

1
Defining the differences between episodic migraine and chronic migraine.定义发作性偏头痛和慢性偏头痛之间的差异。
Curr Pain Headache Rep. 2012 Feb;16(1):86-92. doi: 10.1007/s11916-011-0233-z.
2
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers.慢性偏头痛和发作性偏头痛患者的社会人口学和合并症特征。
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):428-32. doi: 10.1136/jnnp.2009.192492. Epub 2010 Feb 17.
3
Chronic migraine, classification, differential diagnosis, and epidemiology.慢性偏头痛:分类、鉴别诊断与流行病学。
Headache. 2011 Jul-Aug;51 Suppl 2:77-83. doi: 10.1111/j.1526-4610.2011.01954.x.
4
Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme.在日本,发作性偏头痛和慢性偏头痛的真实世界治疗模式和患者报告结局:来自 Adelphi 偏头痛疾病专项计划的数据分析。
J Headache Pain. 2019 Jun 7;20(1):68. doi: 10.1186/s10194-019-1012-1.
5
Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.基于合并症的偏头痛亚组中偏头痛的进展:CaMEO 研究结果。
Neurology. 2019 Dec 10;93(24):e2224-e2236. doi: 10.1212/WNL.0000000000008589. Epub 2019 Nov 5.
6
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.1年内发作性和慢性偏头痛状态的波动:对诊断、治疗及临床试验设计的意义
J Headache Pain. 2017 Oct 4;18(1):101. doi: 10.1186/s10194-017-0787-1.
7
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.验证偏头痛特异性生活质量问卷 v2.1 在发作性和慢性偏头痛中的适用性。
Headache. 2012 Mar;52(3):409-21. doi: 10.1111/j.1526-4610.2011.01997.x. Epub 2011 Sep 19.
8
Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.慢性和阵发性偏头痛的头痛影响:来自美国偏头痛患病率和预防研究的结果。
Headache. 2012 Jan;52(1):3-17. doi: 10.1111/j.1526-4610.2011.02046.x. Epub 2011 Nov 22.
9
Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.发作性和慢性偏头痛的急性治疗优化:美国偏头痛患病率与预防(AMPP)研究结果
Headache. 2015 Apr;55(4):502-18. doi: 10.1111/head.12553.
10
Economic burden and costs of chronic migraine.慢性偏头痛的经济负担和成本。
Curr Pain Headache Rep. 2014 Jan;18(1):385. doi: 10.1007/s11916-013-0385-0.

引用本文的文献

1
Evaluation of macular and peripapillary structure and microvasculature with optical coherence tomography angiography in migraine in the Indian population.印度人群中偏头痛患者黄斑和视乳头周围结构及微血管系统的光学相干断层扫描血管造影评估
World J Methodol. 2025 Sep 20;15(3):100950. doi: 10.5662/wjm.v15.i3.100950.
2
Differences in Patient-Physician Satisfaction for Migraine Treatment Medications in Patients with and without Medication-Overuse Headache: A Cross-Sectional Real-World Survey.有药物过度使用性头痛和无药物过度使用性头痛患者对偏头痛治疗药物的医患满意度差异:一项横断面真实世界调查
Neurol Ther. 2025 Aug 19. doi: 10.1007/s40120-025-00812-z.
3
Neuroinflammatory crosstalk in migraine: consolidated activity of rizatriptan and meloxicam in suppressing CGRP-induced nociception and COX-mediated inflammation.偏头痛中的神经炎症相互作用:利扎曲普坦与美洛昔康在抑制降钙素基因相关肽诱导的伤害感受和环氧化酶介导的炎症方面的联合作用
Inflammopharmacology. 2025 Jul 16. doi: 10.1007/s10787-025-01848-1.
4
What does a migraine aura look like?-A systematic review.偏头痛先兆是什么样的?一项系统综述。
J Headache Pain. 2025 Jul 1;26(1):149. doi: 10.1186/s10194-025-02080-6.
5
Altered perfusion in the locus coeruleus of patients with chronic migraine: a pilot 3D-PCASL study.慢性偏头痛患者蓝斑核灌注改变:一项3D-PCASL初步研究
Brain Imaging Behav. 2025 Jun 3. doi: 10.1007/s11682-025-01020-x.
6
The ocular surface tear film as a biomarker for systemic health.眼表泪膜作为全身健康的生物标志物。
Ocul Surf. 2025 Jul;37:283-300. doi: 10.1016/j.jtos.2025.05.005. Epub 2025 May 8.
7
Real-World Insights into the Effectiveness and Tolerability of OnabotulinumtoxinA in Chronic Migraine: A Long-Term Evaluation of up to 11 Years.关于A型肉毒毒素治疗慢性偏头痛有效性和耐受性的真实世界见解:长达11年的长期评估
Toxins (Basel). 2025 Apr 21;17(4):208. doi: 10.3390/toxins17040208.
8
Unveiling the Public Economic Burden of Migraine in Argentina.揭示阿根廷偏头痛的公共经济负担。
J Health Econ Outcomes Res. 2025 Apr 9;12(1):129-137. doi: 10.36469/001c.133639. eCollection 2025.
9
Migraine and MRI: uncovering potential associations.偏头痛与磁共振成像:揭示潜在关联。
Head Face Med. 2025 Feb 15;21(1):6. doi: 10.1186/s13005-024-00478-2.
10
Cost-Utility Analysis of Erenumab Compared to Topiramate for Preventive Therapy of Migraine in Iran.伊朗依瑞奈单抗与托吡酯用于偏头痛预防性治疗的成本-效用分析
Iran J Pharm Res. 2024 Sep 16;23(1):e146026. doi: 10.5812/ijpr-146026. eCollection 2024 Jan-Dec.

本文引用的文献

1
Depression and risk of transformation of episodic to chronic migraine.抑郁与发作性偏头痛向慢性偏头痛转化的风险。
J Headache Pain. 2012 Nov;13(8):615-24. doi: 10.1007/s10194-012-0479-9. Epub 2012 Sep 25.
2
Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.慢性和阵发性偏头痛的头痛影响:来自美国偏头痛患病率和预防研究的结果。
Headache. 2012 Jan;52(1):3-17. doi: 10.1111/j.1526-4610.2011.02046.x. Epub 2011 Nov 22.
3
Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).加拿大和美国慢性和阵发性偏头痛患者的医疗保健成本:国际偏头痛负担研究(IBMS)的结果。
Headache. 2011 Jul-Aug;51(7):1058-77. doi: 10.1111/j.1526-4610.2011.01945.x.
4
Rates, predictors, and consequences of remission from chronic migraine to episodic migraine.从慢性偏头痛缓解至阵发性偏头痛的频率、预测因素和后果。
Neurology. 2011 Feb 22;76(8):711-8. doi: 10.1212/WNL.0b013e31820d8af2. Epub 2011 Jan 26.
5
Chronic migraine: classification and comparisons.慢性偏头痛:分类与比较。
Cephalalgia. 2011 Apr;31(5):520-9. doi: 10.1177/0333102410383590. Epub 2011 Jan 10.
6
Treatment of chronic migraine.慢性偏头痛的治疗。
Curr Pain Headache Rep. 2011 Feb;15(1):64-9. doi: 10.1007/s11916-010-0159-x.
7
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS).慢性和发作性偏头痛患者的残疾、健康相关生活质量和资源利用:来自国际偏头痛负担研究(IBMS)的结果。
Cephalalgia. 2011 Feb;31(3):301-15. doi: 10.1177/0333102410381145. Epub 2010 Sep 2.
8
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.肉毒杆菌毒素 A 治疗慢性偏头痛:来自 PREEMPT 2 试验双盲、随机、安慰剂对照阶段的结果。
Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.
9
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.肉毒杆菌毒素 A 治疗慢性偏头痛:PREEMPT 1 试验双盲、随机、安慰剂对照阶段的结果。
Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.
10
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.肉毒杆菌毒素 A 治疗慢性偏头痛:PREEMPT 临床研究计划双盲、随机、安慰剂对照阶段的汇总结果。
Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7.